NCT02489916View on ClinicalTrials.gov

Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

December 31, 2015

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

CM4307

CM4307 300mg bid, each 4 week cycle

Trial Locations (1)

610041

West China Hospital,SCU, Chengdu

All Listed Sponsors
lead

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

INDUSTRY

NCT02489916 - Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter